IMAB 0.95 (-5.94%)
US44975P1030BiotechnologyBiotechnology

I-MAB (IMAB) Financial Metrics

This table shows a selected set of financial data points of I-MAB (IMAB). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2023 -2.48 0 -5.44 1.12B -0.43 3.9M -185.69M -169.24M -206.77M 302.1M
2022 -33.01 0 -0.88 2.21B -1.01 -221.56M -1.15B -2.29B -2.51B 3.21B
2022 -4.4 0 -6.61 2.4B -0.16 -32.11M -166.49M -331.64M -363.42M 465.85M
2021 -4.82 0 -62.71 22.94B -0.11 13.81M -157.36M -372.28M -365.78M 552.8M
2021 -30.69 0 -9.84 22.94B -0.39 88.03M -1B -2.37B -2.33B 3.52B
2020 1.24 0 248.86 17.94B 0 236.12M 65.14M 16.45M 72.08M 728.39M
2020 8.07 0 38.09 17.94B 0.13 1.54B 425.55M 107.46M 470.92M 4.76B
2019 0 0 0 0 0 0 0 0 0 0
2019 -25.11 0 0 0 -0.71 30M -880.22M -1.42B -1.45B 1.14B
2018 -13.06 0 0 0 -0.24 53.78M -295.11M -382.68M -402.83M 1.59B
2017 -6.7 0 0 0 0 11.56M -272.48M -290.96M -298.24M 307.93M

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.